Hemodynamically significant sinus bradycardia may require treatment with which of the following?

Prepare for the Telemetry Course Test. Study with quizzes and multiple-choice questions; each question includes hints and explanations. Get ready to excel in your exam!

Hemodynamically significant sinus bradycardia occurs when the heart rate is slower than normal and is accompanied by symptoms such as dizziness, syncope, or hypotension, indicating that the body's organs may not be receiving adequate blood flow. The treatment for this condition aims to increase the heart rate and improve hemodynamics.

Atropine is an anticholinergic medication that works by blocking the vagus nerve's influence on the heart, leading to an increase in heart rate. It is often the first-line treatment for symptomatic bradycardia. Cardiac pacing, either temporary or permanent, is also a viable option when medications do not sufficiently address the issue. Pacing provides direct electrical stimulation to the heart, ensuring a more consistent and effective heart rate that can alleviate symptoms and improve perfusion to vital organs.

Other treatments mentioned, such as amiodarone, are typically used for managing arrhythmias rather than bradycardia. Aspirin is an antiplatelet medication that does not directly affect the heart rate or address bradycardia. Beta-blockers, while they may have a role in certain cardiac conditions, would generally worsen bradycardia by further lowering the heart rate.

Therefore, utilizing atropine or implementing